» Articles » PMID: 35619108

An Individual Nomogram Can Reliably Predict Tumor Spread Through Air Spaces in Non-small-cell Lung Cancer

Overview
Journal BMC Pulm Med
Publisher Biomed Central
Specialty Pulmonary Medicine
Date 2022 May 26
PMID 35619108
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Tumor spread through air spaces (STAS) has been shown to adversely affect the prognosis of lung cancer. The correlation between clinicopathological and genetic features and STAS remains unclear.

Method: We retrospectively reviewed 3075 NSCLC patients between2017-2019. We evaluated the relationship between STAS and patients' clinicopathological and molecular features. The chi-square test was performed to compare categorical variables. Univariate analysis and multivariate logistic regression analysis were performed to investigate the association of clinical factors with STAS. A nomogram was formulated to predict the presence of STAS.

Results: STAS was identified in 617 of 3075 patients (20.07%). STAS was significantly related to sex (p < 0.001), smoking (p < 0.001), CEA (p < 0.001), differentiation (p < 0.001), histopathological type (p < 0.001), lymphatic vessel invasion (p < 0.001), pleural invasion (p < 0.001), T stage (p < 0.001), N stage (p < 0.001), M stage (p < 0.001), and TNM stage (p < 0.001). STAS was frequently found in tumors with wild-type EGFR (p < 0.001), KRAS mutations (p < 0.001), ALK rearrangements (p < 0.001) or ROS1 rearrangements (p < 0.001). For programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1), STAS was associated with PD-L1 expression level in tumor cells (p < 0.001) or stromal cells (p < 0.001), while PD-1 only in stromal cells (p < 0.001). Multivariable analyses demonstrated significant correlations between STAS and CEA level (p < 0.001), pathological grade (p < 0.001), lymphatic vessel invasion (p < 0.001), pleural invasion (p = 0.001), and TNM stage (p = 0.002). A nomogram was formulated based on the results of the multivariable analysis.

Conclusions: Tumor STAS was associated with several invasive clinicopathological features. A nomogram was established to predict the presence of STAS in patients with NSCLC.

Citing Articles

Preoperative CT radiomic model combined with clinical and CT imaging features to predict the spread through air spaces in T1 invasive lung adenocarcinoma.

Xu P, Yu H, Zhao H, Bian H, Jia D, Zhi S Am J Transl Res. 2024; 16(10):6106-6118.

PMID: 39544799 PMC: 11558366. DOI: 10.62347/UJYU8551.


STAS: New explorations and challenges for thoracic surgeons.

Xia T, Yuan Q, Xing S Clin Transl Oncol. 2024; .

PMID: 39230858 DOI: 10.1007/s12094-024-03681-4.


Deep learning-based detection and semi-quantitative model for spread through air spaces (STAS) in lung adenocarcinoma.

Feng Y, Ding H, Huang X, Zhang Y, Lu M, Zhang T NPJ Precis Oncol. 2024; 8(1):173.

PMID: 39103596 PMC: 11300827. DOI: 10.1038/s41698-024-00664-0.


Predictive value of multiple imaging predictive models for spread through air spaces of lung adenocarcinoma: A systematic review and network meta‑analysis.

Liu C, Wang Y, Wang P, Guo F, Zhao H, Wang Q Oncol Lett. 2024; 27(3):122.

PMID: 38348387 PMC: 10859825. DOI: 10.3892/ol.2024.14255.


An individualized nomogram for predicting and validating spread through air space (STAS) in surgically resected lung adenocarcinoma: a single center retrospective analysis.

Wang J, Yao Y, Tang D, Gao W J Cardiothorac Surg. 2023; 18(1):337.

PMID: 37990253 PMC: 10664312. DOI: 10.1186/s13019-023-02458-0.

References
1.
Blaauwgeers H, Flieder D, Warth A, Harms A, Monkhorst K, Witte B . A Prospective Study of Loose Tissue Fragments in Non-Small Cell Lung Cancer Resection Specimens: An Alternative View to "Spread Through Air Spaces". Am J Surg Pathol. 2017; 41(9):1226-1230. DOI: 10.1097/PAS.0000000000000889. View

2.
Lee J, Kim E, Kim M, Shim H . Genetic and clinicopathologic characteristics of lung adenocarcinoma with tumor spread through air spaces. Lung Cancer. 2018; 123:121-126. DOI: 10.1016/j.lungcan.2018.07.020. View

3.
Hirsch F, McElhinny A, Stanforth D, Ranger-Moore J, Jansson M, Kulangara K . PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project. J Thorac Oncol. 2016; 12(2):208-222. DOI: 10.1016/j.jtho.2016.11.2228. View

4.
Wang S, Hao J, Qian C, Wang H . Tumor Spread Through Air Spaces Is a Survival Predictor in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2019; 20(5):e584-e591. DOI: 10.1016/j.cllc.2019.05.012. View

5.
Zeng Q, Wang B, Li J, Zhao J, Mao Y, Gao Y . Solid Nodule Appearance as a Predictor of Tumor Spread Through Air Spaces in Patients with Lung Adenocarcinoma: A Propensity Score Matching Study. Cancer Manag Res. 2020; 12:8197-8207. PMC: 7490081. DOI: 10.2147/CMAR.S266750. View